0.003 next stop, page-7

ALT now a massive avoid IMO

I will sit on what I have remaining in ALT and ALTOA, however I consider them dead unless they pull a miracle (side with a pharma, get bid for their IP etc)

The cash burn is way too high, the sales are woeful and the spend on development is causing massive round of dilution each time they require a CR

They'll need at least another $2-3M, and on a $5M market cap that is 40-60% dilution !

Very poor performance